JAYPRITA Trademark
Trademark Overview
On Tuesday, July 13, 2021, a trademark application was filed for JAYPRITA with the United States Patent and Trademark Office. The USPTO has given the JAYPRITA trademark a serial number of 90825250. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 22, 2024. This trademark is owned by Eli Lilly and Company. The JAYPRITA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
General Information
| Serial Number | 90825250 |
| Word Mark | JAYPRITA |
| Filing Date | Tuesday, July 13, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, January 22, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 26, 2022 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 17, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Eli Lilly and Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285 |
| Party Name | Eli Lilly and Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285 |
Trademark Events
| Event Date | Event Description |
| Monday, January 22, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, January 22, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, May 16, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, May 12, 2023 | SOU EXTENSION 2 GRANTED |
| Friday, May 12, 2023 | SOU EXTENSION 2 FILED |
| Friday, May 12, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, November 23, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, November 22, 2022 | SOU EXTENSION 1 GRANTED |
| Thursday, November 10, 2022 | SOU EXTENSION 1 FILED |
| Tuesday, November 22, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, November 10, 2022 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, June 21, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 26, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 26, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 6, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 22, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, March 21, 2022 | ASSIGNED TO EXAMINER |
| Friday, September 17, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, July 16, 2021 | NEW APPLICATION ENTERED |
